ZEN trial
Las Vegas, NV - Thirty-day and three-month results from an eagerly awaited first trial to test a drug-eluting stent (DES) for the treatment of erectile dysfunction suggest that this novel use for a DES is safe and associated with significant improvement in erectile function and satisfaction.
Interesting trial called the ZEN trial. This showcases that perhaps there is a vascular component to at least a subset of patients with male erectile dysfunciton. The study noted a couple of key points that the pelvic vascular anatomy is complex and the true incidence of internal pudendal artery stenosis is unknown in the erectile dysfunction group.
Some interesting possible applications for future interventionalists in the elderly male population. This would include not only treatment of erectile dysfunction as well as the emerging treatment of BPH with prostatic artery embolization.
Las Vegas, NV - Thirty-day and three-month results from an eagerly awaited first trial to test a drug-eluting stent (DES) for the treatment of erectile dysfunction suggest that this novel use for a DES is safe and associated with significant improvement in erectile function and satisfaction.
Interesting trial called the ZEN trial. This showcases that perhaps there is a vascular component to at least a subset of patients with male erectile dysfunciton. The study noted a couple of key points that the pelvic vascular anatomy is complex and the true incidence of internal pudendal artery stenosis is unknown in the erectile dysfunction group.
Some interesting possible applications for future interventionalists in the elderly male population. This would include not only treatment of erectile dysfunction as well as the emerging treatment of BPH with prostatic artery embolization.